GC Genome to Present the Latest Lung Cancer Diagnostic Tool at ESMO 2023

– An innovative study of methylation markers and deep learning model enables precise lung cancer diagnosis. YONGIN, South Korea, Oct. 20, 2023 /PRNewswire/ — GC Genome Corporation, a leading diagnostics company, today announced that it will present data showcasing deep learning algorithm…